Cleared Traditional

K190937 - Echelon Endopath Staple Line Reinforcement (FDA 510(k) Clearance)

Oct 2019
Decision
187d
Days
Class 2
Risk

K190937 is an FDA 510(k) clearance for the Echelon Endopath Staple Line Reinforcement. This device is classified as a Mesh, Surgical, Absorbable, Staple Line Reinforcement (Class II - Special Controls, product code OXC).

Submitted by Ethicon Endo-Surgery, LLC (Guaynabo, US). The FDA issued a Cleared decision on October 14, 2019, 187 days after receiving the submission on April 10, 2019.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.3300. For Reinforcement Of Soft Tissue Where Weakness Exists During Staple Line Reinforcement Procedures..

Submission Details

510(k) Number K190937 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 10, 2019
Decision Date October 14, 2019
Days to Decision 187 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code OXC — Mesh, Surgical, Absorbable, Staple Line Reinforcement
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.3300
Definition For Reinforcement Of Soft Tissue Where Weakness Exists During Staple Line Reinforcement Procedures.